University of Pennsylvania Pioneers HIV Gene-Therapy Trial
March 28, 2011
University of Pennsylvania researchers are still recruiting HIV-positive participants for a trial of a gene therapy approach intended to block HIV from entering human immune cells. The trial's initial results, presented at the recent 18th Conference on Retroviruses and Opportunistic Infections in Boston, were promising.
"We separate the cells in the lab, and the protein in the membrane of the cell where the HIV virus uses to enter the cells is taken out," Dr. Pablo Tebas said. "So we remove that particular gene from the cells and then monitor the patients to see if the HIV continues to expand or not."
Philadelphia Gay News
03.17.2011; Jen Colletta
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)